{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:48:40Z","timestamp":1789652920645,"version":"4.0.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03506-2","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:17:10Z","timestamp":1737681430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Quality of life in idiopathic pulmonary fibrosis in Latin American countries"],"prefix":"10.1186","volume":"25","author":[{"given":"H.","family":"Aguilar-Duran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rinc\u00f3n-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Caro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"V\u00e1squez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Florenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Florestano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Buendia-Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"3506_CR1","doi-asserted-by":"publisher","unstructured":"Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255st","DOI":"10.1164\/rccm.201807-1255st"},{"issue":"9","key":"3506_CR2","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u201347. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"158","key":"3506_CR3","doi-asserted-by":"publisher","first-page":"200154","DOI":"10.1183\/16000617.0154-2020","volume":"29","author":"IA Cox","year":"2020","unstructured":"Cox IA, Borchers Arriagada N, de Graaff B, Corte TJ, Glaspole I, Lartey S, et al. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Eur Respiratory Rev. 2020;29(158):200154. https:\/\/doi.org\/10.1183\/16000617.0154-2020","journal-title":"Eur Respiratory Rev"},{"issue":"10","key":"3506_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/thx.2010.139121","volume":"65","author":"J Yorke","year":"2010","unstructured":"Yorke J, Jones PW, Swigris JJ. Development and validity testing of an IPF-specific version of the St George\u2019s respiratory questionnaire. Thorax. 2010;65(10):921\u20136. https:\/\/doi.org\/10.1136\/thx.2010.139121","journal-title":"Thorax"},{"key":"3506_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1477-7525-8-77","volume":"8","author":"JJ Swigris","year":"2010","unstructured":"Swigris JJ, Wilson SR, Green KE, Sprunger DB, Brown KK, Wamboldt FS. Development of the ATAQ-IPF: a tool to assess quality of life in IPF. Health Qual Life Outcomes. 2010;8:77. https:\/\/doi.org\/10.1186\/1477-7525-8-77","journal-title":"Health Qual Life Outcomes"},{"key":"3506_CR6","doi-asserted-by":"publisher","unstructured":"Rabin R, Gudex C, Selai C, Herdman M. From translation to version management: a history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value Health. 2014;17(1):70\u20136. https:\/\/doi.org\/10.1016\/j.jval.2013.10.006","DOI":"10.1016\/j.jval.2013.10.006"},{"issue":"9","key":"3506_CR7","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/thoraxjnl-2012-201581","volume":"67","author":"AS Patel","year":"2012","unstructured":"Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, et al. The development and validation of the King\u2019s brief interstitial lung disease (K-BILD) health status questionnaire. Thorax. 2012;67(9):804\u201310. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-201581","journal-title":"Thorax"},{"issue":"6","key":"3506_CR8","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1378\/chest.117.6.1627","volume":"117","author":"TY Martinez","year":"2000","unstructured":"Martinez TY, Pereira CA, dos Santos ML, Ciconelli RM, Guimar\u00e3es SM, Martinez JA. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2000;117(6):1627\u201332. https:\/\/doi.org\/10.1378\/chest.117.6.1627","journal-title":"Chest"},{"issue":"2","key":"3506_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.arbres.2017.09.004","volume":"54","author":"I Capparelli","year":"2018","unstructured":"Capparelli I, Fernandez M, Saadia Otero M, Steimberg J, Brassesco M, Campobasso A, et al. Traducci\u00f3n Al espa\u00f1ol Y validaci\u00f3n Del Cuestionario Saint George espec\u00edfico para fibrosis pulmonar idiop\u00e1tica. Arch Bronconeumol. 2018;54(2):68\u201373. https:\/\/doi.org\/10.1016\/j.arbres.2017.09.004","journal-title":"Arch Bronconeumol"},{"key":"3506_CR10","doi-asserted-by":"publisher","unstructured":"Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, et al. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry. Respir Res. 2017;18(1). https:\/\/doi.org\/10.1186\/s12931-017-0621-y","DOI":"10.1186\/s12931-017-0621-y"},{"issue":"5","key":"3506_CR11","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/resp.12989","volume":"22","author":"IN Glaspole","year":"2017","unstructured":"Glaspole IN, Chapman SA, Cooper WA, Ellis SJ, Goh NS, Hopkins PM, et al. Health-related quality of life in idiopathic pulmonary fibrosis: data from the Australian IPF Registry. Respirology. 2017;22(5):950\u20136. https:\/\/doi.org\/10.1111\/resp.12989","journal-title":"Respirology"},{"issue":"22","key":"3506_CR12","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","volume":"370","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071\u201382. https:\/\/doi.org\/10.1056\/NEJMoa1402584","journal-title":"N Engl J Med"},{"key":"3506_CR13","doi-asserted-by":"publisher","unstructured":"Lee YJ, Choi SM, Lee YJ, Cho YJ, Yoon HI, Lee JH et al. Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis. Loukides S, editor. PLOS ONE. 2017;12(9):e0184300. https:\/\/doi.org\/10.1371\/journal.pone.0184300","DOI":"10.1371\/journal.pone.0184300"},{"issue":"8","key":"3506_CR14","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):e70\u201388. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3506_CR15","doi-asserted-by":"publisher","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","volume":"49","author":"BL Graham","year":"2017","unstructured":"Graham BL, Brusasco V, Burgos F, Cooper BG, Jensen R, Kendrick A, et al. 2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J. 2017;49(1):1600016. https:\/\/doi.org\/10.1183\/13993003.00016-2016","journal-title":"Eur Respir J"},{"issue":"6","key":"3506_CR16","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1183\/09031936.00150314","volume":"44","author":"AE Holland","year":"2014","unstructured":"Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society\/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428\u201346. https:\/\/doi.org\/10.1183\/09031936.00150314","journal-title":"Eur Respir J"},{"issue":"6","key":"3506_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"3506_CR18","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1183\/20734735.012717","volume":"13","author":"BG Cooper","year":"2017","unstructured":"Cooper BG, Stocks J, Hall GL, Culver B, Steenbruggen I, Carter KW, et al. The global lung function initiative (GLI) network: bringing the world\u2019s respiratory reference values together. Breathe (Sheff). 2017;13(3):e56\u201364. https:\/\/doi.org\/10.1183\/20734735.012717","journal-title":"Breathe (Sheff)"},{"issue":"3","key":"3506_CR19","doi-asserted-by":"publisher","first-page":"1801587","DOI":"10.1183\/13993003.01587-2018","volume":"53","author":"SE Torrisi","year":"2018","unstructured":"Torrisi SE, Ley B, Kreuter M, Wijsenbeek M, Vittinghoff E, Collard HR, et al. The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study. Eur Respir J. 2018;53(3):1801587. https:\/\/doi.org\/10.1183\/13993003.01587-2018","journal-title":"Eur Respir J"},{"issue":"12","key":"3506_CR20","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.arbres.2022.04.007","volume":"58","author":"F Caro","year":"2022","unstructured":"Caro F, Buend\u00eda-Rold\u00e1n I, Noriega L, Alberti LM, Fl\u00e1via A, Arbo G, et al. Latin American Registry of Idiopathic Pulmonary Fibrosis (REFIPI): clinical characteristics, evolution and treatment. Arch Bronconeumol. 2022;58(12):794\u2013801. https:\/\/doi.org\/10.1016\/j.arbres.2022.04.007","journal-title":"Arch Bronconeumol"},{"issue":"7","key":"3506_CR21","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/thx.2004.035220","volume":"60","author":"JJ Swigris","year":"2005","unstructured":"Swigris JJ. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax. 2005;60(7):588\u201394. https:\/\/doi.org\/10.1136\/thx.2004.035220","journal-title":"Thorax"},{"issue":"4","key":"3506_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1183\/13993003.02316-2014","volume":"46","author":"G Raghu","year":"2015","unstructured":"Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46(4):1113\u201330. https:\/\/doi.org\/10.1183\/13993003.02316-2014","journal-title":"Eur Respir J"},{"issue":"153","key":"3506_CR23","doi-asserted-by":"publisher","first-page":"190044","DOI":"10.1183\/16000617.0044-2019","volume":"28","author":"A Caminati","year":"2019","unstructured":"Caminati A, Lonati C, Cassandro R, Elia D, Pelosi G, Torre O, et al. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue. Eur Respiratory Rev. 2019;28(153):190044. https:\/\/doi.org\/10.1183\/16000617.0044-2019","journal-title":"Eur Respiratory Rev"},{"key":"3506_CR24","unstructured":"Fernandez M, Rodriguez-Barreto O, Buendia-Roldan I, Alberti M, Caro F, Ipuche F et al. Prevalence of anxiety and depression and their relationship with clinical characteristics in patients with interstitial lung disease. J Gerontol Geriatr. 2019 November 26 Res 8: 505."},{"issue":"3","key":"3506_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1378\/chest.10-0608","volume":"139","author":"CJ Ryerson","year":"2011","unstructured":"Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest. 2011;139(3):609\u201316. https:\/\/doi.org\/10.1378\/chest.10-0608","journal-title":"Chest"},{"issue":"3","key":"3506_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1479972313493098","volume":"10","author":"AA Akhtar","year":"2013","unstructured":"Akhtar AA, Ali MA, Smith RP. Depression in patients with idiopathic pulmonary fibrosis. Chronic Resp Dis. 2013;10(3):127\u201333. https:\/\/doi.org\/10.1177\/1479972313493098","journal-title":"Chronic Resp Dis"},{"issue":"1","key":"3506_CR27","doi-asserted-by":"publisher","first-page":"e000007","DOI":"10.1136\/bmjresp-2013-000007","volume":"1","author":"A Belkin","year":"2014","unstructured":"Belkin A, Albright K, Swigris JJ. A qualitative study of informal caregivers\u2019 perspectives on the effects of idiopathic pulmonary fibrosis. BMJ Open Respiratory Res. 2014;1(1):e000007. https:\/\/doi.org\/10.1136\/bmjresp-2013-000007","journal-title":"BMJ Open Respiratory Res"},{"issue":"3","key":"3506_CR28","doi-asserted-by":"publisher","first-page":"230101","DOI":"10.1183\/20734735.0101-2023","volume":"19","author":"A Oliveira","year":"2023","unstructured":"Oliveira A, Fabbri G, Gille T, Bargagli E, Duchemann B, Evans R, et al. Holistic management of patients with progressive pulmonary fibrosis. Breathe. 2023;19(3):230101\u20131. https:\/\/doi.org\/10.1183\/20734735.0101-2023","journal-title":"Breathe"},{"key":"3506_CR29","doi-asserted-by":"publisher","unstructured":"Gonzalez-Garcia M, Rincon-Alvarez E, Alberti ML, Duran M, Caro F, Venero M del. Comorbidities of patients with idiopathic pulmonary fibrosis in four latin American countries. Are there differences by Country and Altitude? Front Med. 2021;8. https:\/\/doi.org\/10.3389\/fmed.2021.679487","DOI":"10.3389\/fmed.2021.679487"},{"issue":"5","key":"3506_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.chest.2019.11.042","volume":"157","author":"EC O\u2019Brien","year":"2020","unstructured":"O\u2019Brien EC, Hellkamp AS, Neely ML, Swaminathan A, Bender S, Snyder LD, et al. Disease severity and quality of life in patients with idiopathic pulmonary fibrosis. Chest. 2020;157(5):1188\u201398. https:\/\/doi.org\/10.1016\/j.chest.2019.11.042","journal-title":"Chest"},{"issue":"22","key":"3506_CR31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","volume":"370","author":"TE King","year":"2014","unstructured":"King TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1402582","journal-title":"N Engl J Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03506-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03506-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:17:15Z","timestamp":1737681435000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03506-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03506-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research ethics committees of each participating country approved the study: M\u00e9xico: Comit\u00e9 de \u00c9tica e Investigaci\u00f3n Instituto Nacional de Enfermedades Respiratorias. Argentina: Comit\u00e9 de \u00c9tica en Investigaci\u00f3n Hospital Mar\u00eda Ferrer. Colombia: Comit\u00e9 de \u00c9tica en Investigaci\u00f3n de la Fundaci\u00f3n Neumol\u00f3gica Colombiana. Rep\u00fablica Dominicana: Comit\u00e9 de Bio\u00e9tica Cl\u00ednica Universitaria Uni\u00f3n Medica del Norte. Bolivia: Comit\u00e9 de Bio\u00e9tica Biom\u00e9dica. Chile: Comit\u00e9 \u00c9tico-cient\u00edco Servicio de la Salud Metropolitano Oriente del Instituto Nacional del T\u00f3rax. Informed consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"36"}}